scPharmaceuticals Inc. - SCPH Company profit before taxes, interest and amortization
scPharmaceuticals Inc. generates revenue through the sale of the innovative drug FUROSCIX for the home treatment of heart failure. The operating profit history in monetary terms on the precise GURU.Markets chart clearly demonstrates the financial dynamics, where determines this parameter level. Engaging specialized cardiologists expands distribution, while the status of a reliable partner for physicians strengthens the brand's position in non-hospitalized therapy.
Summary analytical data breakdowns for scPharmaceuticals (SCPH)
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio scPharmaceuticals Inc.|SCPH - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient scPharmaceuticals, Inc.|SCPH - Company Aggregate Debts|Debt to Book Value scPharmaceuticals|SCPH - Company Long-Term Debt|Current Liabilities scPharmaceuticals|Intermediate Coverage Ratio scpharmaceuticals.com
- earnings and market ratios statistics:
SCPH - Net Profit|Projected Future Earnings scPharmaceuticals Inc.|SCPH - Price to Earnings Ratio|Future Price to Earnings Multiple scPharmaceuticals, Inc.|SCPH - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio scPharmaceuticals|SCPH - Operating profit EBITDA|Net earnings per share (EPS TTM) scPharmaceuticals|SCPH - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months scpharmaceuticals.com|SCPH - Earnings growth in current year|Expected net earnings per share growth next year scPharmaceuticals Inc.
Summary company analytics:SCPH - scPharmaceuticals Inc.
The scale of operations at scPharmaceuticals Inc. (SCPH) is currently driven by the costs of launching its cardiology drug, which is reflected in the EBITDA history. This indicator captures the actual cash flow from core operations before interest and taxes, allowing for an assessment of whether reserves can cover the current marketing cycle and confirming the fundamental stability of the business during its commercial rollout.
Competitors of scPharmaceuticals Inc. (SCPH)
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Galapagos GLPG|Operating income before deduction of amortization ANI Pharmaceuticals Inc (ANIP)|MannKind Corp. - Operating profit EBITDA|Amphastar Corp (AMPH) - Operating profit before deduction of amortization|Pacira BioSciences (PCRX) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization SPRY (ars-pharma.com)|TBPH (Theravance Biopharma, Inc.) - Operating profit EBITDA|AQST: Income before deduction of interest, taxes and amortization|Operating profit EBITDA TECX|Operating profit EBITDA Tonix Pharmaceuticals Holding (TNXP)|Profit before payment of interest, taxes and amortization China SXT Pharmaceuticals, Inc. SXTC|Income before deduction of interest, taxes and amortization EPRX|BHST - Profit before payment of interest, taxes and amortization|Invizyne Technologies (EXOZ) - Operating profit before deduction of amortization|ORMP: Operating profit EBITDA|Entera Bio (ENTX) - Operating profit EBITDA|HYFT (MindWalk Holdings) - Operating profit EBITDA|Operating profit before deduction of amortization abvcpharma.com (ABVC)|Operating profit EBITDA CPIX|QNTM - Profit before interest, taxes and amortization|FibroGen Corp - Operating profit before deduction of amortization|Operating profit EBITDA Telomir Pharmaceuticals Corp TELO|RANI: Operating profit before deduction of amortization|Synergy CHC Corp - Company profit before taxes, interest and amortization|RLYB: Operating profit EBITDA|LEXX - Operating income before deduction of amortization|PULM (Pulmatrix Corp) - Operating profit EBITDA|Operating profit before deduction of amortization Pheton (PTHL)|Operating profit EBITDA APM|Operating profit EBITDA lyratherapeutics.com (LYRA)|Profit before payment of interest, taxes and amortization Impact BioMedical IBO|TNF Pharmaceuticals Inc. - Profit before payment of interest, taxes and amortization|YCBD - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization PainReform Corp PRFX|CYTO (altamiratherapeutics.com) - Operating profit before deduction of amortization|lipella.com - Income before deduction of interest, taxes and amortization|OPTN (OptiNose) - Operating profit EBITDA|Pieris Pharmaceuticals Inc (PIRS) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Procaps Group SA (PROC)|Petros Pharma - Operating profit before amortization|Operating profit EBITDA QLI (Qilian International)|SLRN - Operating profit before deduction of amortization|TFFP: Operating profit before deduction of amortization
